Bank of Montreal
CYCN icon

Bank of Montreal’s Cyclerion Therapeutics CYCN Stock Holding History

Bank of Montreal’s Portfolio CYCN Stock Details CYCN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-30
Closed -$2K – 3964
2021
Q1 		$2K Sell
30
-141
-82% -$10.6K ﹤0.01% 4893
2020
Q4 		$11K Buy
171
+112
+190% +$7.64K ﹤0.01% 4630
2020
Q3 		$7K Sell
59
-26
-31% -$2.97K ﹤0.01% 4269
2020
Q2 		$10K Buy
+85
New +$7.11K ﹤0.01% 4161
2020
Q1 		– Sell
-153
Closed -$8K – 4216
2019
Q4 		$8K Buy
153
+47
+44% +$4.39K ﹤0.01% 4617
2019
Q3 		$26K Sell
106
-4
-4% -$864 ﹤0.01% 3941
2019
Q2 		$25K Buy
+110
New +$31.1K ﹤0.01% 4047

Other funds holding CYCN

SPC
Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return
MP
MFN Partners Boston, Massachusetts $4.77B AUM 72.29% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Bank of Montreal's CYCN Position: Q2 2021 in Review

Bank of Montreal sold out of Cyclerion Therapeutics (CYCN) in Q2 2021, closing a stake of 30 shares — an estimated $2K sold.

Bank of Montreal first reported a position in CYCN in Q2 2019 and held it in 7 quarters. The position peaked at $26K in Q3 2019. 67 funds tracked by Wall St. Rank hold CYCN as of Q2 2021.

  • Bank of Montreal reported no remaining Cyclerion Therapeutics position as of Q2 2021 after selling out during the quarter.
  • Bank of Montreal sold 30 Cyclerion Therapeutics shares in Q2 2021, an estimated $2K.
  • Bank of Montreal first reported a position in Cyclerion Therapeutics in Q2 2019 and held it in 7 quarters.
  • Bank of Montreal's Cyclerion Therapeutics position peaked at $26K in Q3 2019.
  • 67 funds tracked by Wall St. Rank held Cyclerion Therapeutics as of Q2 2021.

Based on Bank of Montreal's 13F filing for Q2 2021, filed 12 Aug 2021.